schizophrenia

Boehringer Ingelheim and Sosei Heptares Forge Global Collaboration to Pioneer Precision Treatment for Schizophrenia

(IN BRIEF) Boehringer Ingelheim and Sosei Group Corporation (Sosei Heptares) have unveiled a global collaboration and exclusive option-to-license agreement aimed…

2 months ago

University of Twente associate professor Kerensa Broersen granted a Vici funding from NWO, the Dutch Research Council

(PRESS RELEASE) ENSCHEDE, Netherlands, 28-Feb-2022 — /EuropaWire/ — University of Twente, a Enschede, NL based public technical university, has announced…

2 years ago

Discovery of microRNA cluster that regulates synaptic strength may point to new therapeutic strategies for the treatment of social deficits in neurodevelopmental disorders

Researchers uncover how a microRNA cluster regulates synapse development and sociability HEIDELBERG, 17-Dec-2018 — /EuropaWire/ — The recent discovery of microRNAs as…

5 years ago

H. Lundbeck A/S and Otsuka Pharmaceutical Co., Ltd. announce European Commission approval for Rxulti® (brexpiprazole) for the treatment of schizophrenia in adults

Rxulti® (brexpiprazole) has been approved for the treatment of schizophrenia in adults. VALBY, 01-Aug-2018 — /EuropaWire/ — H. Lundbeck A/S (Lundbeck)…

6 years ago

Novartis, Pear Therapeutics to work together towards developing new treatments for patients with schizophrenia and multiple sclerosis

Novartis and Pear Therapeutics to collaborate on prescription software applications aimed to treat patients with schizophrenia and multiple sclerosis Collaboration…

6 years ago

UCL scientists discovered rare gene variant associated with increased risk of developing schizophrenia, bipolar disorder and alcoholism

A rare gene variant discovered by UCL scientists is associated with an increased risk of developing schizophrenia, bipolar disorder and…

10 years ago